Disclosure

Name: McLin Valérie

Date: 23.02.2026


Consulting fees

Entity with whom you have this relationship: Ipsen Pharmaceuticals
Details / Comments: institution
Percentage: <5%
Estimate % of your annual research income from this activity: 0%


Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events

Entity with whom you have this relationship: Ipsen Pharmaceuticals
Details / Comments: institution
Percentage: 0%
Estimate % of your annual research income from this activity: 0%


Payment for expert testimony

Entity with whom you have this relationship: Ipsen Pharmaceuticals
Details / Comments: institution
Percentage: 0%
Estimate % of your annual research income from this activity: 0%


Support for attending meetings and/or travel

Entity with whom you have this relationship: Ipsen Pharmaceuticals
Details / Comments: instituion
Percentage: 0%
Estimate % of your annual research income from this activity: 0%


Safety Monitoring Board or Advisory Board

Entity with whom you have this relationship: Mirum Pharmaceuticals
Details / Comments: institution
Percentage: <1%
Estimate % of your annual research income from this activity: 0%